| 08/06/2026 3:04 PM | TriSalus Life Sciences (1826667) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/07/2026 3:39 PM | First Light Asset Management, LLC (1600004) Filed by TriSalus Life Sciences (1826667) Subject | Form SCHEDULE 13G/A | |
| 07/06/2026 3:01 PM | Patience David (1970009) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2026 3:01 PM | Marshak Richard (1982638) Reporting TriSalus Life Sciences (1826667) Issuer | Form 5 Annual statement of changes in beneficial ownership of securities | |
| 07/01/2026 3:02 PM | Marshak Richard (1982638) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2026 3:03 PM | Szela Mary T (1410289) Reporting TriSalus Life Sciences (1826667) Issuer | Form 5 Annual statement of changes in beneficial ownership of securities | |
| 07/01/2026 3:04 PM | Szela Mary T (1410289) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/29/2026 3:30 PM | Marshall Richard Henry (2142265) Reporting TriSalus Life Sciences (1826667) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 06/29/2026 3:33 PM | Marshall Richard Henry (2142265) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 3:42 PM | Gordon Gary B. (1811354) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 3:42 PM | Patience David (1970009) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TLSIW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for TriSalus Life Sciences and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/18/2026 3:42 PM | Szela Mary T (1410289) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 3:42 PM | Stansky Michael P (1424204) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 3:42 PM | TriSalus Life Sciences (1826667) Issuer Wahlstrom Mats (1459154) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 3:44 PM | First Light Asset Management, LLC (1600004) Filed by TriSalus Life Sciences (1826667) Subject | Form SCHEDULE 13G | |
| 05/12/2026 3:03 PM | TriSalus Life Sciences (1826667) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/12/2026 7:30 AM | TriSalus Life Sciences (1826667) Subject Utmost Group Plc (2046077) Filed by | Form SCHEDULE 13G | |
| 04/29/2026 3:32 PM | TriSalus Life Sciences (1826667) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/20/2026 3:36 PM | Frankenius Equity AB (1988262) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/07/2026 8:10 AM | TriSalus Life Sciences (1826667) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/01/2026 3:09 PM | MATLIN DAVID J (1251956) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/20/2026 3:25 PM | Szela Mary T (1410289) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/20/2026 3:25 PM | Stevens Jennifer (1982621) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/20/2026 3:25 PM | Marshak Richard (1982638) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/20/2026 3:25 PM | Cox Bryan F. (1981787) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/20/2026 3:25 PM | Devlin Jodi (1992151) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 3:08 PM | TriSalus Life Sciences (1826667) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/26/2026 3:31 PM | TriSalus Life Sciences (1826667) Filer | Form 424B5 | |
| 02/23/2026 3:08 PM | Stansky Michael P (1424204) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 3:08 PM | Szela Mary T (1410289) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 3:08 PM | TriSalus Life Sciences (1826667) Issuer Valle William (2018493) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 3:08 PM | Gordon Gary B. (1811354) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 3:08 PM | Patience David (1970009) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 3:15 PM | TriSalus Life Sciences (1826667) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/11/2026 5:50 PM | Stansky Michael P (1424204) Reporting TriSalus Life Sciences (1826667) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/11/2026 5:51 PM | Stansky Michael P (1424204) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/09/2026 7:59 AM | TriSalus Life Sciences (1826667) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/12/2026 6:09 AM | TriSalus Life Sciences (1826667) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/04/2025 11:15 PM | TriSalus Life Sciences (1826667) Filer | Form EFFECT | |
| 11/25/2025 3:15 PM | Cox Bryan F. (1981787) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 2:40 PM | Patience David (1970009) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad) Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states.
The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now. See which companies control the supply chain behind this emerging tech |
| 11/25/2025 2:42 PM | Marshak Richard (1982638) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 2:43 PM | Stevens Jennifer (1982621) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 2:55 PM | Szela Mary T (1410289) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 2:56 PM | Devlin Jodi (1992151) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/13/2025 3:40 PM | TriSalus Life Sciences (1826667) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 11/03/2025 9:00 AM | TriSalus Life Sciences (1826667) Subject Utmost Group Plc (2046077) Filed by | Form SCHEDULE 13G | |
| 10/01/2025 3:28 PM | TriSalus Life Sciences (1826667) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |